These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38947346)

  • 1. Efficacy of polygenic risk scores and digital technologies for INNOvative personalized cardiovascular disease PREVention in high-risk adults: protocol of a randomized controlled trial.
    Pastorino R; Pezzullo AM; Agodi A; de Waure C; Mazzucco W; Russo L; Bianchi M; Maio A; Farina S; Porcelli M; Tona DM; Di Pumpo M; Amore R; Wachocka M; Pasciuto T; Barchitta M; Magnano San Lio R; Favara G; Tuttolomondo A; Tramuto F; Morello G; De Bella DD; Fruscione S; Severino A; Liuzzo G; Boccia S
    Front Public Health; 2024; 12():1335894. PubMed ID: 38947346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of training community health workers and their interventions on cardiovascular disease risk factors among adults in Morogoro, Tanzania: study protocol for a cluster randomized controlled trial.
    Muhihi AJ; Urassa DP; Mpembeni RNM; Leyna GH; Sunguya BF; Kakoko D; Kessy AT; Njelekela MA
    Trials; 2018 Oct; 19(1):552. PubMed ID: 30314511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
    Palmer MJ; Barnard S; Perel P; Free C
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012675. PubMed ID: 29932455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polygenic risk score adds to a clinical risk score in the prediction of cardiovascular disease in a clinical setting.
    Samani NJ; Beeston E; Greengrass C; Riveros-McKay F; Debiec R; Lawday D; Wang Q; Budgeon CA; Braund PS; Bramley R; Kharodia S; Newton M; Marshall A; Krzeminski A; Zafar A; Chahal A; Heer A; Khunti K; Joshi N; Lakhani M; Farooqi A; Plagnol V; Donnelly P; Weale ME; Nelson CP
    Eur Heart J; 2024 Sep; 45(34):3152-3160. PubMed ID: 38848106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic versus opportunistic risk assessment for the primary prevention of cardiovascular disease.
    Dyakova M; Shantikumar S; Colquitt JL; Drew CM; Sime M; MacIver J; Wright N; Clarke A; Rees K
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD010411. PubMed ID: 26824223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Task shifting of cardiovascular risk assessment and communication by nurses for primary and secondary prevention of cardiovascular diseases in a tertiary health care setting of Northern India.
    Kavita ; Thakur JS; Vijayvergiya R; Ghai S
    BMC Health Serv Res; 2020 Jan; 20(1):10. PubMed ID: 31900134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A polygenic risk score added to a QRISK®2 cardiovascular disease risk calculator demonstrated robust clinical acceptance and clinical utility in the primary care setting.
    Fuat A; Adlen E; Monane M; Coll R; Groves S; Little E; Wild J; Kamali FJ; Soni Y; Haining S; Riding H; Riveros-Mckay F; Peneva I; Lachapelle A; Giner-Delgado C; Weale ME; Plagnol V; Harrison S; Donnelly P
    Eur J Prev Cardiol; 2024 Apr; 31(6):716-722. PubMed ID: 38243727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis.
    Pinto ACPN; Piva SR; Rocha A; Gomes-Neto M; Atallah ÁN; Saconato H; Trevisani VF
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD014605. PubMed ID: 37294546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease.
    Rees K; Takeda A; Martin N; Ellis L; Wijesekara D; Vepa A; Das A; Hartley L; Stranges S
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD009825. PubMed ID: 30864165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polygenic risk score for blood pressure and lifestyle factors with overall and CVD mortality: a prospective cohort study in a Japanese population.
    Fujii R; Hishida A; Nakatochi M; Okumiyama H; Takashima N; Tsuboi Y; Suzuki K; Ikezaki H; Shimanoe C; Kato Y; Tamura T; Ito H; Michihata N; Tanoue S; Suzuki S; Kuriki K; Kadota A; Watanabe T; Momozawa Y; Wakai K; Matsuo K;
    Hypertens Res; 2024 Sep; 47(9):2284-2294. PubMed ID: 38961281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Information and Risk Modification Trial (INFORM): design of a randomised controlled trial of communicating different types of information about coronary heart disease risk, alongside lifestyle advice, to achieve change in health-related behaviour.
    Silarova B; Lucas J; Butterworth AS; Di Angelantonio E; Girling C; Lawrence K; Mackintosh S; Moore C; Payne RA; Sharp SJ; Shefer G; Tolkien Z; Usher-Smith J; Walker M; Danesh J; Griffin S
    BMC Public Health; 2015 Sep; 15():868. PubMed ID: 26345710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk scoring for the primary prevention of cardiovascular disease.
    Karmali KN; Persell SD; Perel P; Lloyd-Jones DM; Berendsen MA; Huffman MD
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD006887. PubMed ID: 28290160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular disease risk reduction in rural China: a clustered randomized controlled trial in Zhejiang.
    Wei X; Zou G; Gong W; Yin J; Yu Y; Walley J; Zhang Z; King R; Chen K; Chong MK; Zee BC; Liu S; Tang J; Griffiths S; Yu M
    Trials; 2013 Oct; 14():354. PubMed ID: 24160442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega 6 fatty acids for the primary prevention of cardiovascular disease.
    Al-Khudairy L; Hartley L; Clar C; Flowers N; Hooper L; Rees K
    Cochrane Database Syst Rev; 2015 Nov; (11):CD011094. PubMed ID: 26571451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of a polygenic score into guideline-recommended prediction of cardiovascular disease.
    Li L; Pang S; Starnecker F; Mueller-Myhsok B; Schunkert H
    Eur Heart J; 2024 May; 45(20):1843-1852. PubMed ID: 38551411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tailored lifestyle intervention to reduce the cardiovascular disease risk of individuals with Familial Hypercholesterolemia (FH): design of the PRO-FIT randomised controlled trial.
    Broekhuizen K; van Poppel MN; Koppes LL; Brug J; van Mechelen W
    BMC Public Health; 2010 Feb; 10():69. PubMed ID: 20156339
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.